Skip to main content
Clinical Trials/PACTR202407805328722
PACTR202407805328722Not yet recruitingPhase 4

Effect of hyoscine N-Butyl bromide on progress of labour and pregnancy outcome; A randomized control trial

Rahmat Adamu0 sites128 target enrollmentStarted: February 8, 2024Last updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor
Enrollment
128

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
19 Year(s) to 44 Year(s) (—)
Sex
Female

Inclusion Criteria

  • 1. Pregnant women with term pregnancy gravida 1 to gravida 5
  • 2.Those that consented to partake in the study
  • 3.Aged 18 and above
  • 4.Women in active phase of labour
  • 5.Women with no contraindication to drug use
  • 6.Singleton foetus at term
  • 7.Cephalic presentation

Exclusion Criteria

  • 1. Women with contraindication to vaginal delivery
  • 2.Women with any present or past obstetric emergency/complication
  • 3.Intrauterine fetal Death (IUFD)
  • 4.Fully dilated
  • 5.Suspected fetal distress

Investigators

Sponsor
Rahmat Adamu

Similar Trials